The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:115: 154847-154847 被引量:6
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Alienwalker发布了新的文献求助10
刚刚
bjyx发布了新的文献求助30
刚刚
科研通AI6.1应助夏姬宁静采纳,获得10
刚刚
1秒前
XIETTING完成签到 ,获得积分10
1秒前
2秒前
义气的惜霜完成签到 ,获得积分10
2秒前
过客完成签到,获得积分10
2秒前
情怀应助高高的海云采纳,获得10
3秒前
gchen001完成签到,获得积分10
3秒前
程永丽发布了新的文献求助20
3秒前
3秒前
枫枫829发布了新的文献求助10
3秒前
wll发布了新的文献求助50
3秒前
UY完成签到 ,获得积分20
3秒前
4秒前
甜心完成签到,获得积分10
4秒前
阿呆关注了科研通微信公众号
4秒前
猫蒲完成签到,获得积分10
4秒前
4秒前
Kristine完成签到 ,获得积分10
4秒前
9298488完成签到,获得积分10
4秒前
xm发布了新的文献求助10
5秒前
无情夏槐完成签到,获得积分10
6秒前
6秒前
行走的土豆完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
狂野酒窝发布了新的文献求助10
8秒前
luria完成签到,获得积分10
8秒前
xuzhu0907完成签到,获得积分10
8秒前
在水一方应助吃饱了嘛采纳,获得10
9秒前
iitj发布了新的文献求助12
9秒前
9秒前
在水一方应助南拥夏栀采纳,获得10
9秒前
123456完成签到,获得积分10
10秒前
11秒前
万疾完成签到,获得积分10
11秒前
ykk完成签到,获得积分10
11秒前
高分求助中
GL 2 A method for assessing the in-place cleanability of food processing equipment, Fourth Edition, December 2023 3000
Annie Ernaux: De la perte au corps glorieux 600
Writing Systems 500
类器官构建与应用:从基础到前沿 500
Electric Vehicle Powertrains Design Fundamentals, Components, and Applications 400
Handbook on Planning and Climate Change Adaptation 400
Optical Coating Design with the Essential Macleod 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6810087
求助须知:如何正确求助?哪些是违规求助? 8526318
关于积分的说明 18150144
捐赠科研通 6135285
什么是DOI,文献DOI怎么找? 3029489
邀请新用户注册赠送积分活动 2006082
关于科研通互助平台的介绍 2003982